Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data.

Critical care explorations

Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M.
PMID: 32166230
Crit Care Explor. 2019 Oct 14;1(10):e0049. doi: 10.1097/CCE.0000000000000049. eCollection 2019 Oct.

Variability in hospital-level sepsis mortality rates may be due to differences in case mix, quality of care, or diagnosis and coding practices. Centers for Disease Control and Prevention's Adult Sepsis Event definition could facilitate objective comparisons of sepsis mortality...

Cite
Rhee C, Wang R, Song Y, et al. Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Crit Care Explor. 2019;1(10):e0049doi: 10.1097/CCE.0000000000000049.
Rhee, C., Wang, R., Song, Y., Zhang, Z., Kadri, S. S., Septimus, E. J., Fram, D., Jin, R., Poland, R. E., Hickok, J., Sands, K., & Klompas, M. (2019). Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Critical care explorations, 1(10), e0049. https://doi.org/10.1097/CCE.0000000000000049
Rhee, Chanu, et al. "Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data." Critical care explorations vol. 1,10 (2019): e0049. doi: https://doi.org/10.1097/CCE.0000000000000049
Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M. Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data. Crit Care Explor. 2019 Oct 14;1(10):e0049. doi: 10.1097/CCE.0000000000000049. eCollection 2019 Oct. PMID: 32166230; PMCID: PMC7063887.
Copy Download .nbib Format: NLM
Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals.

Critical care explorations

Kuye I, Anand V, Klompas M, Chan C, Kadri SS, Rhee C.
PMID: 33786449
Crit Care Explor. 2021 Mar 16;3(3):e0373. doi: 10.1097/CCE.0000000000000373. eCollection 2021 Mar.

OBJECTIVES: Some patients diagnosed with sepsis have very brief hospitalizations. Understanding the prevalence and clinical characteristics of these patients may provide insight into how sepsis diagnoses are being applied as well as the breadth of illnesses encompassed by current...

Cite
Kuye I, Anand V, Klompas M, et al. Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Crit Care Explor. 2021;3(3):e0373doi: 10.1097/CCE.0000000000000373.
Kuye, I., Anand, V., Klompas, M., Chan, C., Kadri, S. S., & Rhee, C. (2021). Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Critical care explorations, 3(3), e0373. https://doi.org/10.1097/CCE.0000000000000373
Kuye, Ifedayo, et al. "Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals." Critical care explorations vol. 3,3 (2021): e0373. doi: https://doi.org/10.1097/CCE.0000000000000373
Kuye I, Anand V, Klompas M, Chan C, Kadri SS, Rhee C. Prevalence and Clinical Characteristics of Patients With Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Crit Care Explor. 2021 Mar 16;3(3):e0373. doi: 10.1097/CCE.0000000000000373. eCollection 2021 Mar. PMID: 33786449; PMCID: PMC7994044.
Copy Download .nbib Format: NLM
Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018.

JAMA pediatrics

Hsu HE, Mathew R, Wang R, Broadwell C, Horan K, Jin R, Rhee C, Lee GM.
PMID: 33017011
JAMA Pediatr. 2020 Dec 01;174(12):1176-1183. doi: 10.1001/jamapediatrics.2020.3223.

IMPORTANCE: Central catheter-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs) increase morbidity, mortality, and health care costs in pediatric patients.OBJECTIVE: To examine changes over time in CLABSI and CAUTI rates between 2013 and 2018 in neonatal intensive...

Cite
Hsu HE, Mathew R, Wang R, et al. Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018. JAMA Pediatr. 2020;174(12):1176-1183doi: 10.1001/jamapediatrics.2020.3223.
Hsu, H. E., Mathew, R., Wang, R., Broadwell, C., Horan, K., Jin, R., Rhee, C., & Lee, G. M. (2020). Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018. JAMA pediatrics, 174(12), 1176-1183. https://doi.org/10.1001/jamapediatrics.2020.3223
Hsu, Heather E, et al. "Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018." JAMA pediatrics vol. 174,12 (2020): 1176-1183. doi: https://doi.org/10.1001/jamapediatrics.2020.3223
Hsu HE, Mathew R, Wang R, Broadwell C, Horan K, Jin R, Rhee C, Lee GM. Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018. JAMA Pediatr. 2020 Dec 01;174(12):1176-1183. doi: 10.1001/jamapediatrics.2020.3223. PMID: 33017011; PMCID: PMC7536620.
Copy Download .nbib Format: NLM
Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?.

Journal of thoracic disease

Rhee C, Klompas M.
PMID: 32148931
J Thorac Dis. 2020 Feb;12:S89-S100. doi: 10.21037/jtd.2019.12.51.

Numerous studies suggest that the incidence of sepsis has been steadily increasing over the past several decades while mortality rates are falling. However, reliably assessing trends in sepsis epidemiology is challenging due to changing diagnosis and coding practices over...

Cite
Rhee C, Klompas M. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?. J Thorac Dis. 2020;12:S89-S100doi: 10.21037/jtd.2019.12.51.
Rhee, C., & Klompas, M. (2020). Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?. Journal of thoracic disease, 12S89-S100. https://doi.org/10.21037/jtd.2019.12.51
Rhee, Chanu, and Klompas, Michael. "Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?." Journal of thoracic disease vol. 12 (2020): S89-S100. doi: https://doi.org/10.21037/jtd.2019.12.51
Rhee C, Klompas M. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?. J Thorac Dis. 2020 Feb;12:S89-S100. doi: 10.21037/jtd.2019.12.51. PMID: 32148931; PMCID: PMC7024753.
Copy Download .nbib Format: NLM
Impact of the 2012 Medicaid Health Care-Acquired Conditions Policy on Catheter-Associated Urinary Tract Infection and Vascular Catheter-Associated Infection Billing Rates.

Open forum infectious diseases

Rhee C, Wang R, Jentzsch MS, Hsu H, Kawai AT, Jin R, Horan K, Broadwell C, Lee GM.
PMID: 30191157
Open Forum Infect Dis. 2018 Sep 04;5(9):ofy204. doi: 10.1093/ofid/ofy204. eCollection 2018 Sep.

In July 2012, the Centers for Medicare & Medicaid Services ceased hospital Medicaid reimbursements for certain health care-acquired conditions. Using billing data from 2008-2014, we found no impact of this policy on rates of 2 targeted conditions, vascular catheter-associated...

Cite
Rhee C, Wang R, Jentzsch MS, et al. Impact of the 2012 Medicaid Health Care-Acquired Conditions Policy on Catheter-Associated Urinary Tract Infection and Vascular Catheter-Associated Infection Billing Rates. Open Forum Infect Dis. 2018;5(9):ofy204doi: 10.1093/ofid/ofy204.
Rhee, C., Wang, R., Jentzsch, M. S., Hsu, H., Kawai, A. T., Jin, R., Horan, K., Broadwell, C., & Lee, G. M. (2018). Impact of the 2012 Medicaid Health Care-Acquired Conditions Policy on Catheter-Associated Urinary Tract Infection and Vascular Catheter-Associated Infection Billing Rates. Open forum infectious diseases, 5(9), ofy204. https://doi.org/10.1093/ofid/ofy204
Rhee, Chanu, et al. "Impact of the 2012 Medicaid Health Care-Acquired Conditions Policy on Catheter-Associated Urinary Tract Infection and Vascular Catheter-Associated Infection Billing Rates." Open forum infectious diseases vol. 5,9 (2018): ofy204. doi: https://doi.org/10.1093/ofid/ofy204
Rhee C, Wang R, Jentzsch MS, Hsu H, Kawai AT, Jin R, Horan K, Broadwell C, Lee GM. Impact of the 2012 Medicaid Health Care-Acquired Conditions Policy on Catheter-Associated Urinary Tract Infection and Vascular Catheter-Associated Infection Billing Rates. Open Forum Infect Dis. 2018 Sep 04;5(9):ofy204. doi: 10.1093/ofid/ofy204. eCollection 2018 Sep. PMID: 30191157; PMCID: PMC6121224.
Copy Download .nbib Format: NLM
Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018.

JAMA pediatrics

Hsu HE, Mathew R, Wang R, Broadwell C, Horan K, Jin R, Rhee C, Lee GM.
PMID: 33017011
JAMA Pediatr. 2020 Dec 01;174(12):1176-1183. doi: 10.1001/jamapediatrics.2020.3223.

IMPORTANCE: Central catheter-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs) increase morbidity, mortality, and health care costs in pediatric patients.OBJECTIVE: To examine changes over time in CLABSI and CAUTI rates between 2013 and 2018 in neonatal intensive...

Cite
Hsu HE, Mathew R, Wang R, et al. Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018. JAMA Pediatr. 2020;174(12):1176-1183doi: 10.1001/jamapediatrics.2020.3223.
Hsu, H. E., Mathew, R., Wang, R., Broadwell, C., Horan, K., Jin, R., Rhee, C., & Lee, G. M. (2020). Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018. JAMA pediatrics, 174(12), 1176-1183. https://doi.org/10.1001/jamapediatrics.2020.3223
Hsu, Heather E, et al. "Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018." JAMA pediatrics vol. 174,12 (2020): 1176-1183. doi: https://doi.org/10.1001/jamapediatrics.2020.3223
Hsu HE, Mathew R, Wang R, Broadwell C, Horan K, Jin R, Rhee C, Lee GM. Health Care-Associated Infections Among Critically Ill Children in the US, 2013-2018. JAMA Pediatr. 2020 Dec 01;174(12):1176-1183. doi: 10.1001/jamapediatrics.2020.3223. PMID: 33017011; PMCID: PMC7536620.
Copy Download .nbib Format: NLM
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Rhee C, Kanjilal S, Baker M, Klompas M.
PMID: 33029620
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.

Defining the duration of infectivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has major implications for public health and infection control practice in healthcare facilities. Early in the pandemic, most hospitals required 2 negative RT-PCR tests before discontinuing...

Cite
Rhee C, Kanjilal S, Baker M, et al. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?. Clin Infect Dis. 2021;72(8):1467-1474doi: 10.1093/cid/ciaa1249.
Rhee, C., Kanjilal, S., Baker, M., & Klompas, M. (2021). Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(8), 1467-1474. https://doi.org/10.1093/cid/ciaa1249
Rhee, Chanu, et al. "Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 72,8 (2021): 1467-1474. doi: https://doi.org/10.1093/cid/ciaa1249
Rhee C, Kanjilal S, Baker M, Klompas M. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?. Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249. PMID: 33029620; PMCID: PMC7499497.
Copy Download .nbib Format: NLM
External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals.

Open forum infectious diseases

Kadri SS, Lai YLE, Ricotta EE, Strich JR, Babiker A, Rhee C, Klompas M, Dekker JP, Powers JH, Danner RL, Adjemian J.
PMID: 31240236
Open Forum Infect Dis. 2019 Feb 28;6(4):ofz110. doi: 10.1093/ofid/ofz110. eCollection 2019 Apr.

Difficult-to-treat resistance (DTR; ie, co-resistance to all first-line antibiotics) in gram-negative bloodstream infection (GNBSI) is associated with decreased survival in administrative data models. We externally validated DTR prevalence and associated mortality risk in GNBSI using detailed clinical data from...

Cite
Kadri SS, Lai YLE, Ricotta EE, et al. External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals. Open Forum Infect Dis. 2019;6(4):ofz110doi: 10.1093/ofid/ofz110.
Kadri, S. S., Lai, Y. L. E., Ricotta, E. E., Strich, J. R., Babiker, A., Rhee, C., Klompas, M., Dekker, J. P., Powers, J. H., Danner, R. L., Adjemian, J. (2019). External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals. Open forum infectious diseases, 6(4), ofz110. https://doi.org/10.1093/ofid/ofz110
Kadri, Sameer S, et al. "External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals." Open forum infectious diseases vol. 6,4 (2019): ofz110. doi: https://doi.org/10.1093/ofid/ofz110
Kadri SS, Lai YLE, Ricotta EE, Strich JR, Babiker A, Rhee C, Klompas M, Dekker JP, Powers JH, Danner RL, Adjemian J. External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals. Open Forum Infect Dis. 2019 Feb 28;6(4):ofz110. doi: 10.1093/ofid/ofz110. eCollection 2019 Apr. PMID: 31240236; PMCID: PMC6441782.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries